Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Impact of Treatment Intensity and Factor VIII Products On the Development On High Titre Inhibitors in Children with Severe Hemophilia A: Results of a Non-Concurrent Cohort Study.

Karin Kurnik, MD, Susan Halimeh, MD, Daniela Manner, MD, Susanne Holzhauer, MD, Carmen Escuriola Ettingshausen, MD, Rosemarie Schobess, MD, Ulrike Nowak-Gottl, MD

Blood (2009) 114 (22): 1303.

https://doi.org/10.1182/blood.V114.22.1303.1303

Published: 2009

Journal Articles

Presence of Factor V Leiden or Prothrombin Mutation Influence Inhibitor Development in Children with Severe Hemophilia A: Data of a Multicenter Cohort Study

Karin Kurnik, Christoph Bidlingmaier, Christine During, Susan Halimeh, Rosemarie Schobess, Ulrike Nowak-Gottl, MD

Blood (2008) 112 (11): 242.

https://doi.org/10.1182/blood.V112.11.242.242

Published: 2008

Journal Articles

Effects of “Primary Prophylaxis” and “On-Demand” Therapy on the Clinical Expression of Severe Hemophilia A in Children - Results of a Multicenter Study.

Rosemarie Schobess, Karin Kurnik, Wolfhart Kreuz, Frauke Friedrichs, Anne Krumpel, Christoph Bidlingmaier, Carmen Escuriola Ettingshausen, Ulrike Nowak-Gottl

Blood (2007) 110 (11): 3146.

https://doi.org/10.1182/blood.V110.11.3146.3146

Published: 2007

Journal Articles

European Collaborative Paediatric Database on Cerebral Venous Thrombosis: Risk Factors for Recurrent Venous Thromboembolism.

Gili Kenet, MD, Fenella Kirkham, MD, Thomas Niederstadt, MD, Karin Kurnik, MD, Rosemarie Schobess, MD, Ralf Knofler, MD, Barbara Zieger, MD, Ulrike Nowak-Gottl, MD

Blood (2006) 108 (11): 276.

https://doi.org/10.1182/blood.V108.11.276.276

Published: 2006

Journal Articles

Long-Term Safety and Efficacy Data on Childhood Venous Thrombosis Treated with Enoxaparin: An Open Label Survey of Once-Daily Versus Twice-Daily Administration.

Ulrike Nowak-Gottl, MD, Christine During, MD, Christoph Bidlingmaier, MD, Nick Merkel, MD, Rosemarie Schobess, MD

Blood (2005) 106 (11): 549.

https://doi.org/10.1182/blood.V106.11.549.549

Published: 2005

Journal Articles

Factor V G1691A and Factor II G20210A Mutations and Clinical Expression of Severe Hemophilia A (< 2%) in Children: Impact on Bleeding Episodes and Joint Damage.

Ulrike Nowak-Gottl, MD, Carmen Escuriola, MD, Rosemarie Schobess, MD, Christine Duering, MD, Christoph Bidlingmaier, MD, Hartmut Pollmann, MD, Sylvia Horneff, MD, Karin Kurnik, MD

Blood (2004) 104 (11): 3095.

https://doi.org/10.1182/blood.V104.11.3095.3095

Published: 2004

Journal Articles

Renal venous thrombosis in neonates: prothrombotic risk factors and long-term follow-up

Andrea Kosch, Eberhard Kuwertz-Bröking, Christine Heller, Karin Kurnik, Rosemarie Schobess, Ulrike Nowak-Göttl, for the Childhood Thrombophilia Study Group

Blood (2004) 104 (5): 1356–1360.

https://doi.org/10.1182/blood-2004-01-0229

Published: 2004

Journal Articles

Elevated lipoprotein(a) concentration is an independent risk factor of venous thromboembolism

Ulrike Nowak-Göttl, Rosemarie Schobess, Karin Kurnik, Dirk Schwabe, Gudrun Fleischhack, Ralf Junker

Blood (2002) 99 (9): 3476–3478.

https://doi.org/10.1182/blood-2002-01-0100

Published: 2002

Journal Articles

Catheter-related thrombosis in children with hemophilia A: evidence of a multifactorial disease

Carmen Escuriola Ettingshausen, Karin Kurnik, Rosemarie Schobess, Wolfart D. Kreuz, Susan Halimeh, Hartmut Pollman, Ulrike Nowak-Göttl

Blood (2002) 99 (4): 1499.

https://doi.org/10.1182/blood.V99.4.1499

Published: 2002

Journal Articles

Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors

Ulrike Nowak-Göttl, Ralf Junker, Wolfhart Kreuz, Arnold von Eckardstein, Andrea Kosch, Natascha Nohe, Rosemarie Schobess, Silke Ehrenforth

Blood (2001) 97 (4): 858–862.

https://doi.org/10.1182/blood.V97.4.858

Published: 2001

NARROW

Impact of Treatment Intensity and Factor VIII Products On the Development On High Titre Inhibitors in Children with Severe Hemophilia A: Results of a Non-Concurrent Cohort Study.

Presence of Factor V Leiden or Prothrombin Mutation Influence Inhibitor Development in Children with Severe Hemophilia A: Data of a Multicenter Cohort Study

Effects of “Primary Prophylaxis” and “On-Demand” Therapy on the Clinical Expression of Severe Hemophilia A in Children - Results of a Multicenter Study.

European Collaborative Paediatric Database on Cerebral Venous Thrombosis: Risk Factors for Recurrent Venous Thromboembolism.

Long-Term Safety and Efficacy Data on Childhood Venous Thrombosis Treated with Enoxaparin: An Open Label Survey of Once-Daily Versus Twice-Daily Administration.

Factor V G1691A and Factor II G20210A Mutations and Clinical Expression of Severe Hemophilia A (< 2%) in Children: Impact on Bleeding Episodes and Joint Damage.

Renal venous thrombosis in neonates: prothrombotic risk factors and long-term follow-up

Elevated lipoprotein(a) concentration is an independent risk factor of venous thromboembolism

Catheter-related thrombosis in children with hemophilia A: evidence of a multifactorial disease

Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only